Search

Your search keyword '"Chiu, Brian"' showing total 388 results
Start Over Author "Chiu, Brian" Language english
388 results on '"Chiu, Brian"'

1. LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA

Author

Cui, Xiao-Long, Nie, Ji, Zhu, Houxiang, Kowitwanich, Krissana, Beadell, Alana V., West-Szymanski, Diana C., Zhang, Zhou, Dougherty, Urszula, Kwesi, Akushika, Deng, Zifeng, Li, Yan, Meng, Danqing, Roggin, Kevin, Barry, Teresa, Owyang, Ryan, Fefferman, Ben, Zeng, Chang, Gao, Lu, Zhao, Carolyn W. T., Malina, Yuri, Wei, Jiangbo, Weigert, Melanie, Kang, Wenjun, Goel, Ajay, Chiu, Brian C.-H., Bissonnette, Marc, Zhang, Wei, Chen, Mengjie, and He, Chuan

Published
2024
Full Text
View/download PDF

3. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Author

Berndt, Sonja I., Vijai, Joseph, Benavente, Yolanda, Camp, Nicola J., Nieters, Alexandra, Wang, Zhaoming, Smedby, Karin E., Kleinstern, Geffen, Hjalgrim, Henrik, Besson, Caroline, Skibola, Christine F., Morton, Lindsay M., Brooks-Wilson, Angela R., Teras, Lauren R., Breeze, Charles, Arias, Joshua, Adami, Hans-Olov, Albanes, Demetrius, Anderson, Kenneth C., Ansell, Stephen M., Bassig, Bryan, Becker, Nikolaus, Bhatti, Parveen, Birmann, Brenda M., Boffetta, Paolo, Bracci, Paige M., Brennan, Paul, Brown, Elizabeth E., Burdett, Laurie, Cannon-Albright, Lisa A., Chang, Ellen T., Chiu, Brian C. H., Chung, Charles C., Clavel, Jacqueline, Cocco, Pierluigi, Colditz, Graham, Conde, Lucia, Conti, David V., Cox, David G., Curtin, Karen, Casabonne, Delphine, De Vivo, Immaculata, Diepstra, Arjan, Diver, W. Ryan, Dogan, Ahmet, Edlund, Christopher K., Foretova, Lenka, Fraumeni, Jr, Joseph F., Gabbas, Attilio, Ghesquières, Hervé, Giles, Graham G., Glaser, Sally, Glenn, Martha, Glimelius, Bengt, Gu, Jian, Habermann, Thomas M., Haiman, Christopher A., Haioun, Corinne, Hofmann, Jonathan N., Holford, Theodore R., Holly, Elizabeth A., Hutchinson, Amy, Izhar, Aalin, Jackson, Rebecca D., Jarrett, Ruth F., Kaaks, Rudolph, Kane, Eleanor, Kolonel, Laurence N., Kong, Yinfei, Kraft, Peter, Kricker, Anne, Lake, Annette, Lan, Qing, Lawrence, Charles, Li, Dalin, Liebow, Mark, Link, Brian K., Magnani, Corrado, Maynadie, Marc, McKay, James, Melbye, Mads, Miligi, Lucia, Milne, Roger L., Molina, Thierry J., Monnereau, Alain, Montalvan, Rebecca, North, Kari E., Novak, Anne J., Onel, Kenan, Purdue, Mark P., Rand, Kristin A., Riboli, Elio, Riby, Jacques, Roman, Eve, Salles, Gilles, Sborov, Douglas W., Severson, Richard K., Shanafelt, Tait D., Smith, Martyn T., Smith, Alexandra, Song, Kevin W., Song, Lei, Southey, Melissa C., Spinelli, John J., Staines, Anthony, Stephens, Deborah, Sutherland, Heather J., Tkachuk, Kaitlyn, Thompson, Carrie A., Tilly, Hervé, Tinker, Lesley F., Travis, Ruth C., Turner, Jenny, Vachon, Celine M., Vajdic, Claire M., Van Den Berg, Anke, Van Den Berg, David J., Vermeulen, Roel C. H., Vineis, Paolo, Wang, Sophia S., Weiderpass, Elisabete, Weiner, George J., Weinstein, Stephanie, Doo, Nicole Wong, Ye, Yuanqing, Yeager, Meredith, Yu, Kai, Zeleniuch-Jacquotte, Anne, Zhang, Yawei, Zheng, Tongzhang, Ziv, Elad, Sampson, Joshua, Chatterjee, Nilanjan, Offit, Kenneth, Cozen, Wendy, Wu, Xifeng, Cerhan, James R., Chanock, Stephen J., Slager, Susan L., and Rothman, Nathaniel

Published
2022
Full Text
View/download PDF

4. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Author

Berndt, Sonja I., Vijai, Joseph, Benavente, Yolanda, Camp, Nicola J., Nieters, Alexandra, Wang, Zhaoming, Smedby, Karin E., Kleinstern, Geffen, Hjalgrim, Henrik, Besson, Caroline, Skibola, Christine F., Morton, Lindsay M., Brooks-Wilson, Angela R., Teras, Lauren R., Breeze, Charles, Arias, Joshua, Adami, Hans-Olov, Albanes, Demetrius, Anderson, Kenneth C., Ansell, Stephen M., Bassig, Bryan, Becker, Nikolaus, Bhatti, Parveen, Birmann, Brenda M., Boffetta, Paolo, Bracci, Paige M., Brennan, Paul, Brown, Elizabeth E., Burdett, Laurie, Cannon-Albright, Lisa A., Chang, Ellen T., Chiu, Brian C. H., Chung, Charles C., Clavel, Jacqueline, Cocco, Pierluigi, Colditz, Graham, Conde, Lucia, Conti, David V., Cox, David G., Curtin, Karen, Casabonne, Delphine, De Vivo, Immaculata, Diepstra, Arjan, Diver, W. Ryan, Dogan, Ahmet, Edlund, Christopher K., Foretova, Lenka, Fraumeni, Jr, Joseph F., Gabbas, Attilio, Ghesquières, Hervé, Giles, Graham G., Glaser, Sally, Glenn, Martha, Glimelius, Bengt, Gu, Jian, Habermann, Thomas M., Haiman, Christopher A., Haioun, Corinne, Hofmann, Jonathan N., Holford, Theodore R., Holly, Elizabeth A., Hutchinson, Amy, Izhar, Aalin, Jackson, Rebecca D., Jarrett, Ruth F., Kaaks, Rudolph, Kane, Eleanor, Kolonel, Laurence N., Kong, Yinfei, Kraft, Peter, Kricker, Anne, Lake, Annette, Lan, Qing, Lawrence, Charles, Li, Dalin, Liebow, Mark, Link, Brian K., Magnani, Corrado, Maynadie, Marc, McKay, James, Melbye, Mads, Miligi, Lucia, Milne, Roger L., Molina, Thierry J., Monnereau, Alain, Montalvan, Rebecca, North, Kari E., Novak, Anne J., Onel, Kenan, Purdue, Mark P., Rand, Kristin A., Riboli, Elio, Riby, Jacques, Roman, Eve, Salles, Gilles, Sborov, Douglas W., Severson, Richard K., Shanafelt, Tait D., Smith, Martyn T., Smith, Alexandra, Song, Kevin W., Song, Lei, Southey, Melissa C., Spinelli, John J., Staines, Anthony, Stephens, Deborah, Sutherland, Heather J., Tkachuk, Kaitlyn, Thompson, Carrie A., Tilly, Hervé, Tinker, Lesley F., Travis, Ruth C., Turner, Jenny, Vachon, Celine M., Vajdic, Claire M., Van Den Berg, Anke, Van Den Berg, David J., Vermeulen, Roel C. H., Vineis, Paolo, Wang, Sophia S., Weiderpass, Elisabete, Weiner, George J., Weinstein, Stephanie, Doo, Nicole Wong, Ye, Yuanqing, Yeager, Meredith, Yu, Kai, Zeleniuch-Jacquotte, Anne, Zhang, Yawei, Zheng, Tongzhang, Ziv, Elad, Sampson, Joshua, Chatterjee, Nilanjan, Offit, Kenneth, Cozen, Wendy, Wu, Xifeng, Cerhan, James R., Chanock, Stephen J., Slager, Susan L., and Rothman, Nathaniel

Published
2023
Full Text
View/download PDF

5. A proteome‐wide analysis unveils a core Epstein–Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.

Author

Sarathkumara, Yomani D., Xian, Rena R., Liu, Zhiwei, Yu, Kelly J., Chan, John K. C., Kwong, Yok‐Lam, Lam, Tai Hing, Liang, Raymond, Chiu, Brian, Xu, Jun, Hu, Wei, Ji, Bu‐Tian, Coghill, Anna E., Kelly, Ashton M., Pfeiffer, Ruth M., Rothman, Nathaniel, Ambinder, Richard F., Hildesheim, Allan, Lan, Qing, and Proietti, Carla

Subjects
VIRAL antibodies, HUMORAL immunity, ANTIBODY formation, HODGKIN'S disease, ONCOGENIC viruses
Abstract

Epstein–Barr virus (EBV) is an oncogenic virus associated with various malignancies, including classical Hodgkin lymphoma (cHL). Despite its known association, the specific role of humoral immune response to EBV remains poorly characterized in cHL. To address this, we conducted a study using a custom protein microarray to measure the antibody responses in cHL patients and matched healthy controls recruited from an East‐Asian hospital‐based case–control study. We identified 16 IgG antibodies significantly elevated in EBV‐positive cHL compared with controls, defining an "East‐Asian antibody signature of EBV‐positive cHL." We evaluated responses against these 16 antibodies in a distinct European population, leveraging data from our previous European cHL case–control study from the UK, Denmark, and Sweden. A subset of antibodies (14/16, 87.5%) from the "East‐Asian antibody signature of EBV‐positive cHL" exhibited significant associations with cHL in the European population. Conversely, we assessed the "European antibody signature of EBV‐positive cHL" identified in our prior study which consisted of 18 EBV antibodies (2 IgA, 16 IgG), in the East‐Asian population. A subset of these antibodies (15/18, 83.3%) maintained significant associations with cHL in the East‐Asian population. This cross‐comparison of antibody signatures underscores the robust generalizability of EBV antibodies across populations. Five anti‐EBV IgG antibodies (LMP‐1, TK, BALF2, BDLF3, and BBLF1), found in both population‐specific antibody signatures, represent a "core signature of EBV‐positive cHL." Our findings suggest that the antibody responses targeting these core EBV proteins reflect a specific EBV gene expression pattern, serving as potential biomarkers for EBV‐positive cHL independent of population‐specific factors. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

Author

Au, Wing-Yan, Chiu, Brian, Fan, Lei, Li, Zheng, LAM, Tai Hing, Liang, Raymond, Yeh, Su-Peng, Xu, Jun, Ip, Dennis Kai Ming, Li, Gandi, Xu, Gang, Wang, Xiaodong, Bai, Ou, Cai, Qing-Qing, Xia, Yi, Chen, Jie-Rong, Luo, Chun-Ling, Xiong, Xiang-Yu, Zeng, Yanni, Wei, Pan-Pan, Liu, Chu-Jun, Liu, Yu-Xiang, Cao, Yu-Lu, He, Shuai, Liu, Yang, Ha, Jeslin Chian Hung, Khoo, Lay Poh, Kee, Rebecca Xiangpin, Tan, Jing, Liu, Yanhui, Zhang, Fen, Feng, Yanfen, Rao, Huilan, Chng, Wee Joo, Chan, Jason Yong Sheng, Somasundaram, Nagavalli D/O, Tao, Miriam, Ras, Mohamad Farid Bin Harunal, Yeoh, Kheng-Wei, Goh, Yeow Tee, Ong, Shin Yeu, Grigoropoulos, Nicholas Francis, Wong, Esther Kam Yin, Pang, Jane Wan Lu, Lim, Jing Quan, Chia, Burton Kuan Hui, Kim, Seok Jin, Yoon, Sang Eun, Choi, Seungkyu, Kuo, Ching-Yuan, Chen, Tsai-Yun, Su, Yu-Chieh, Huang, Wen-Tsung, Lee, Ming-Yang, Yao, Wenxiu, Ngan, Kai-Cheong, Liu, Herman, Lee, Harold, Yip, Sze-Fai, Liu, Jie, Li, Jianyong, Rabkin, Charles S., Berndt, Sonja, Bassig, Bryan, Hu, Wei, Zhao, Mingfeng, Li, Yuming, Zhai, Qiongli, Shao, Zonghong, Qiu, Lugui, Wang, Jianxiang, Xu, Fu-Ping, Chen, Ling, Hou, Yu, Xu, Shuangnian, Huang, Zhen, Xie, Mingling, Li, Ming, Zhong, Shilong, Zhang, Yan, Gu, Dongqing, Wang, Xin, Foo, Jia Nee, Li, Zhiqiang, Dai, Juncheng, Sun, Liangdan, Wang, Zhenzhen, Liu, Hong, Zhou, Hui, Sun, Yonghu, Koh, Woon-Puay, Heng, Chew-Kiat, Hong, Chew Soo, Ahn, Jeeyun, Park, Kyu Hyung, Tin, Aung, Gu, Jieruo, Xia, Xiaojun, Li, Bo, Yu, Xueqing, Lin, Guo-Wang, Xu, Caigang, Chen, Kexin, Huang, Hui-Qiang, Chen, Jieping, Song, Bao, Chan, John K C, Li, Wenyu, Liu, Weiping, Shih, Lee-Yung, Chuang, Wen-Yu, Kim, Won Seog, Tan, Wen, Peng, Rou-Jun, Laurensia, Yurike, Cheah, Daryl Ming Zhe, Huang, DaChuan, Cheng, Chee Leong, Su, Yi-Jiun, Tan, Soo-Yong, Ng, Siok-Bian, Tang, Tiffany Pooi Ling, Han, Kyudong, Wang, Vivien Ya-Fan, Jia, Wei-Hua, Pei, Zhong, Li, Ya-Jun, Gao, Song, Shi, Yongyong, Hu, Zhibin, Zhang, Furen, Zhang, Ben, Zeng, Yi-Xin, Shen, Hongbing, He, Lin, Ong, Choon Kiat, Lim, Soon Thye, Chanock, Stephen, Kwong, Yok-Lam, Lin, Dongxin, Rothman, Nathaniel, Khor, Chiea Chuen, Lan, Qing, and Bei, Jin-Xin

Published
2020
Full Text
View/download PDF

11. A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Author

Du, Zhaohui, Weinhold, Niels, Song, Gregory Chi, Rand, Kristin A., Van Den Berg, David J., Hwang, Amie E., Sheng, Xin, Hom, Victor, Ailawadhi, Sikander, Nooka, Ajay K., Singhal, Seema, Pawlish, Karen, Peters, Edward S., Bock, Cathryn, Mohrbacher, Ann, Stram, Alexander, Berndt, Sonja I., Blot, William J., Casey, Graham, Stevens, Victoria L., Kittles, Rick, Goodman, Phyllis J., Diver, W. Ryan, Hennis, Anselm, Nemesure, Barbara, Klein, Eric A., Rybicki, Benjamin A., Stanford, Janet L., Witte, John S., Signorello, Lisa, John, Esther M., Bernstein, Leslie, Stroup, Antoinette M., Stephens, Owen W., Zangari, Maurizio, Van Rhee, Frits, Olshan, Andrew, Zheng, Wei, Hu, Jennifer J., Ziegler, Regina, Nyante, Sarah J., Ingles, Sue Ann, Press, Michael F., Carpten, John David, Chanock, Stephen J., Mehta, Jayesh, Colditz, Graham A., Wolf, Jeffrey, Martin, Thomas G., Tomasson, Michael, Fiala, Mark A., Terebelo, Howard, Janakiraman, Nalini, Kolonel, Laurence, Anderson, Kenneth C., Le Marchand, Loic, Auclair, Daniel, Chiu, Brian C.-H., Ziv, Elad, Stram, Daniel, Vij, Ravi, Bernal-Mizrachi, Leon, Morgan, Gareth J., Zonder, Jeffrey A., Huff, Carol Ann, Lonial, Sagar, Orlowski, Robert Z., Conti, David V., Haiman, Christopher A., and Cozen, Wendy

Published
2020
Full Text
View/download PDF

12. Blood transfusion history and risk of non-Hodgkin lymphoma : an InterLymph pooled analysis

Author

Cerhan, James R., Kane, Eleanor, Vajdic, Claire M., Linet, Martha S., Monnereau, Alain, Bernstein, Leslie, de Sanjose, Silvia, Chiu, Brian C.-H, Spinelli, John J., Maso, Luigino Dal, Zhang, Yawei, Larrabee, Beth R., Cozen, Wendy, Smith, Alexandra G., Clavel, Jacqueline, Serraino, Diego, Zheng, Tongzhang, Holly, Elizabeth A., Weisenberger, Dennis D., Slager, Susan L., and Bracci, Paige M.

Published
2019

15. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma

Author

Liu, Zhiwei, Sarathkumara, Yomani D., Chan, John K. C., Kwong, Yok-Lam, Lam, Tai Hing, Ip, Dennis Kai Ming, Chiu, Brian C.-H., Xu, Jun, Su, Yu-Chieh, Proietti, Carla, Cooper, Martha M., Yu, Kelly J., Bassig, Bryan, Liang, Raymond, Hu, Wei, Ji, Bu-Tian, Coghill, Anna E., Pfeiffer, Ruth M., Hildesheim, Allan, Rothman, Nathaniel, Doolan, Denise L., and Lan, Qing

Published
2021
Full Text
View/download PDF

19. Pooled study of occupational exposure to aromatic hydrocarbon solvents and risk of multiple myeloma

Author

De Roos, Anneclaire J, Spinelli, John, Brown, Elizabeth B, Atanackovic, Djordje, Baris, Dalsu, Bernstein, Leslie, Bhatti, Parveen, Camp, Nicola J, Chiu, Brian C, Clavel, Jacqueline, Cozen, Wendy, De Sanjosé, Silvia, Dosman, James A, Hofmann, Jonathan N, McLaughlin, John R, Miligi, Lucia, Monnereau, Alain, Orsi, Laurent, Purdue, Mark P, Schinasi, Leah H, Tricot, Guido J, Wang, Sophia S, Zhang, Yawei, Birmann, Brenda M, and Cocco, Pierluigi

Published
2018

25. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium

Author

Gibson, Todd M., Smedby, Karin E., Skibola, Christine F., Hein, David W., Slager, Susan L., de Sanjosé, Silvia, Vajdic, Claire M., Zhang, Yawei, Chiu, Brian C.-H., Wang, Sophia S., Hjalgrim, Henrik, Nieters, Alexandra, Bracci, Paige M., Kricker, Anne, Zheng, Tongzhang, Kolar, Carol, Cerhan, James R., Darabi, Hatef, Becker, Nikolaus, Conde, Lucia, Holford, Theodore R., Weisenburger, Dennis D., De Roos, Anneclaire J., Butterbach, Katja, Riby, Jacques, Cozen, Wendy, Benavente, Yolanda, Palmers, Casey, Holly, Elizabeth A., Sampson, Joshua N., Rothman, Nathaniel, Armstrong, Bruce K., and Morton, Lindsay M.

Published
2013

26. Meat intake and risk of non-Hodgkin lymphoma

Author

Aschebrook-Kilfoy, Briseis, Ollberding, Nicholas J., Kolar, Carol, Lawson, Terence A., Smith, Sonali M., Weisenburger, Dennis D., and Chiu, Brian C.-H.

Published
2012

32. Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury.

Author

Vergara, Ander, Wang, Kaiming, Colombo, Daniele, Gheblawi, Mahmoud, Rasmuson, Jaslyn, Mandal, Rupasri, Nonno, Franca Del, Chiu, Brian, Scholey, James W, Soler, María José, Wishart, David S, and Oudit, Gavin Y

Subjects
SARS-CoV-2, ANGIOTENSIN converting enzyme, COVID-19, ESSENTIAL amino acids, LIPOCALIN-2
Abstract

Background Angiotensin-converting enzyme 2 (ACE2), the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly expressed in the kidneys. Beyond serving as a crucial endogenous regulator of the renin–angiotensin system, ACE2 also possess a unique function to facilitate amino acid absorption. Our observational study sought to explore the relationship between urine ACE2 (uACE2) and renal outcomes in coronavirus disease 2019 (COVID-19). Methods In a cohort of 104 patients with COVID-19 without acute kidney injury (AKI), 43 patients with COVID-19-mediated AKI and 36 non-COVID-19 controls, we measured uACE2, urine tumour necrosis factor receptors I and II (uTNF-RI and uTNF-RII) and neutrophil gelatinase-associated lipocalin (uNGAL). We also assessed ACE2 staining in autopsy kidney samples and generated a propensity score–matched subgroup of patients to perform a targeted urine metabolomic study to describe the characteristic signature of COVID-19. Results uACE2 is increased in patients with COVID-19 and further increased in those that developed AKI. After adjusting uACE2 levels for age, sex and previous comorbidities, increased uACE2 was independently associated with a >3-fold higher risk of developing AKI [odds ratio 3.05 (95% confidence interval 1.23‒7.58), P  = .017]. Increased uACE2 corresponded to a tubular loss of ACE2 in kidney sections and strongly correlated with uTNF-RI and uTNF-RII. Urine quantitative metabolome analysis revealed an increased excretion of essential amino acids in patients with COVID-19, including leucine, isoleucine, tryptophan and phenylalanine. Additionally, a strong correlation was observed between urine amino acids and uACE2. Conclusions Elevated uACE2 is related to AKI in patients with COVID-19. The loss of tubular ACE2 during SARS-CoV-2 infection demonstrates a potential link between aminoaciduria and proximal tubular injury. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

33. Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis.

Author

Boyle, Terry, Kleinstern, Geffen, Bracci, Paige M., Cerhan, James R., Benavente, Yolanda, Casabonne, Delphine, Chiu, Brian C.‐H., Habermann, Thomas M., Holly, Elizabeth A., Liebow, Mark, Norman, Aaron, Paltiel, Ora, Robinson, Dennis, Rothman, Nathaniel, Abu Seir, Rania, Slager, Susan L., Villeneuve, Paul J., Wang, Sophia S., Weisenburger, Dennis D., and Spinelli, John J.

Subjects
NON-Hodgkin's lymphoma, PHYSICAL activity, T-cell lymphoma, MUCOSA-associated lymphoid tissue lymphoma, FOLLICULAR lymphoma, DIFFUSE large B-cell lymphomas, CHRONIC leukemia
Abstract

Non‐Hodgkin lymphoma (NHL) is composed of a heterogeneous collection of subtypes with considerable differences in genetics, biology and aetiology. Studies to date on physical activity and NHL risk have not had sufficient sample size to evaluate whether associations differ by subtype. We pooled data from nine case‐control studies to examine the association between moderate‐to‐vigorous intensity physical activity (MVPA) and risk of NHL overall and by subtype (diffuse large B‐cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia/small lymphocytic lymphoma, marginal zone lymphoma and mature T‐cell lymphoma). A total of 5653 cases and 9115 controls were included in the pooled analysis. Physical activity was harmonised across nine studies and modelled as study‐specific tertiles. Multinomial logistic regression was used to estimate the association between physical activity and NHL, adjusting for confounders. The overall odds of NHL was 13% lower among participants in the most active tertile of MVPA compared to the least active tertile (adjusted odds ratio = 0.87, 95% CI = 0.80, 0.95). Similar decreases were observed across NHL subtypes. In summary, in this pooled analysis of case‐control studies, physical activity was associated with a modest risk reduction for each NHL subtype examined and with overall NHL. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma.

Author

Wang, Bei, Derman, Benjamin A., Langerman, Spencer S., Johnson, Julie, Zhang, Wei, Jakubowiak, Andrzej, and Chiu, Brian C.-H.

Subjects
MULTIPLE myeloma diagnosis, STATURE, OBESITY, BODY weight, CONFIDENCE intervals, TIME, SELF-evaluation, LOG-rank test, ACQUISITION of data, CANCER patients, SEX distribution, PEARSON correlation (Statistics), RISK assessment, SURVIVAL analysis (Biometry), MEDICAL records, QUESTIONNAIRES, KAPLAN-Meier estimator, BODY mass index, MULTIPLE myeloma, STATISTICAL models, DATA analysis software, OVERALL survival, LONGITUDINAL method, PROPORTIONAL hazards models
Abstract

Simple Summary: There is a growing need to clarify the effect of modifiable lifestyle factors such as obesity on outcomes of multiple myeloma (MM). In this paper, we examined the associations between body mass index (BMI) at different periods of life up to the time of diagnosis and overall survival among patients newly diagnosed with multiple myeloma. The key findings are that BMIs before and at the time of diagnosis were not associated with overall survival in MM, except that a higher BMI at diagnosis was associated with a better overall survival for females, irrespective of race/ethnicity. This is the first evidence that the BMI-survival association may differ by sex. Obesity is associated with survival in several solid tumors and non-Hodgkin lymphoma, but its impact on multiple myeloma (MM) survival is unclear. We examined the associations between body mass index (BMI) at different periods of life up to the time of diagnosis and overall survival (OS) among 563 patients newly diagnosed with MM in 2010–2019. BMI at diagnosis was calculated using measured height and weight from electronic medical records (EMR). BMIs at age 20, maximum during adulthood, and 5 years before diagnosis were calculated using self-reported weights and measured height from EMR. Over a median follow-up of 49.3 months, 191 (33.93%) deaths were identified. We used multivariable Cox proportional-hazards models to examine the associations between BMIs and OS. Height as well as BMI before and at diagnosis was not associated with OS, but there is a U-shape association between weight and OS. Higher BMIs at diagnosis were associated with better OS among females (HR = 0.39 [0.22–0.71]), irrespective of race. In conclusion, our results suggest that BMI at different periods of life up to the time of diagnosis may not be associated with OS in MM, except that a higher BMI at diagnosis was associated with superior OS for females. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

43. Physical functioning, frailty and risks of locally-advanced breast cancer among older women.

Author

Coleman, Chandler, Yan, Connie H., Ko, Naomi Y., Nabulsi, Nadia A., Hoskins, Kent F., Chiu, Brian C.-H., and Calip, Gregory S.

Subjects
PHYSICAL mobility, OLDER women, BREAST cancer, EARLY detection of cancer, FRAILTY, HORMONE receptor positive breast cancer
Abstract

Women with multiple comorbidities have competing health needs that may delay screening for early detection of breast cancer. Our objective was to determine associations between physical functioning and frailty with risk of locally-advanced breast cancer (BC). We conducted a retrospective cohort study of women 65 years and older diagnosed with first primary stage I-III BC using the Surveillance, Epidemiology and End Results Medicare Health Outcome Survey Data Resource. Physical health-related quality of life was measured using Veterans RAND 12 Item Health Survey scales within two years before diagnosis; frailty was determined by calculating deficit-accumulation frailty index (DAFI) scores. Multivariable modified Poisson regression models were used to estimate rate ratios (RR) and 95% confidence intervals (CI) for risk of locally-advanced (stage III) versus early-stage (I-II) BC. Among 2411 women with a median age of 75 years at BC diagnosis, 2189 (91%) were diagnosed with incident stage I-II BC and 222 (9%) were diagnosed at stage III. Compared to women with early-stage disease, women with locally-advanced BC had lower physical component scores (37.8 vs. 41.4) and more classified as pre-frail or frail (55% vs. 50%). In multivariable models, frailty was not associated with increased risk of locally-advanced disease. However, worse physical function subscale scores (lowest vs. upper quartile; RR = 1.56, 95% CI 1.04–2.34) were associated with risk of locally-advanced BC. Breast cancer screening among non-frail older women should be personalized to include women with limited physical functioning if the benefits of screening and early detection outweigh the potential harms. • Older women have competing health needs that may delay early detection of breast cancer. • Women with locally-advanced disease had lower health-related quality of life prior to diagnosis. • Worse physical functioning was associated with risk of locally-advanced breast cancer. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

45. Targeting NLRP3 Inflammasome in an Animal Model for SARS‐CoV‐2

Author

Sergi, Consolato M. and Chiu, Brian

Subjects
Coronavirus, Inflammasomes, SARS-CoV-2, Cytokine/Chemokine, NLR Family, Pyrin Domain-Containing 3 Protein, Humans, SARS Coronavirus, Letter to the Editor, Hydroxychloroquine, COVID-19 Drug Treatment
Published
2020

50. Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis

Author

Becker, Nikolaus, Falster, Michael O., Vajdic, Claire M., de Sanjose, Silvia, Martínez-Maza, Otoniel, Bracci, Paige M., Melbye, Mads, Smedby, Karin Ekström, Engels, Eric A., Turner, Jennifer, Vineis, Paolo, Costantini, Adele Seniori, Holly, Elizabeth A., Spinelli, John J., Vecchia, Carlo La, Zheng, Tongzhang, Chiu, Brian C.-H., Montella, Maurizio, Cocco, Pierluigi, Maynadié, Marc, Foretova, Lenka, Staines, Anthony, Brennan, Paul, Davis, Scott, Severson, Richard, Cerhan, James R., Breen, Elizabeth C., Birmann, Brenda, Cozen, Wendy, Grulich, Andrew E., and Newton, Robert

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results